ZA907936B - Novel alpha-glucosidase inhibitors - Google Patents
Novel alpha-glucosidase inhibitorsInfo
- Publication number
- ZA907936B ZA907936B ZA907936A ZA907936A ZA907936B ZA 907936 B ZA907936 B ZA 907936B ZA 907936 A ZA907936 A ZA 907936A ZA 907936 A ZA907936 A ZA 907936A ZA 907936 B ZA907936 B ZA 907936B
- Authority
- ZA
- South Africa
- Prior art keywords
- glucosidase inhibitors
- novel alpha
- alpha
- novel
- glucosidase
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/044—Pyrrole radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/26—Acyclic or carbocyclic radicals, substituted by hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Biotechnology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Virology (AREA)
- Endocrinology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Child & Adolescent Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP89402794A EP0422307A1 (en) | 1989-10-10 | 1989-10-10 | Novel alpha-glucosidase inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA907936B true ZA907936B (en) | 1991-08-28 |
Family
ID=8202997
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA907936A ZA907936B (en) | 1989-10-10 | 1990-10-04 | Novel alpha-glucosidase inhibitors |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US5097023A (pt) |
| EP (2) | EP0422307A1 (pt) |
| JP (1) | JP3032266B2 (pt) |
| KR (1) | KR0183012B1 (pt) |
| CN (1) | CN1029974C (pt) |
| AR (1) | AR246745A1 (pt) |
| AT (1) | ATE109153T1 (pt) |
| AU (1) | AU632855B2 (pt) |
| CA (1) | CA2027276C (pt) |
| DE (1) | DE69011033T2 (pt) |
| DK (1) | DK0422975T3 (pt) |
| ES (1) | ES2060980T3 (pt) |
| FI (1) | FI101796B (pt) |
| HU (1) | HU209724B (pt) |
| IE (1) | IE64079B1 (pt) |
| IL (1) | IL95928A (pt) |
| NO (1) | NO174203C (pt) |
| NZ (1) | NZ235578A (pt) |
| PT (1) | PT95547B (pt) |
| TW (1) | TW225539B (pt) |
| ZA (1) | ZA907936B (pt) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5504078A (en) * | 1990-06-08 | 1996-04-02 | Merrell Dow Pharmaceuticals Inc. | α-glucosidase inhibitors |
| US5268364A (en) * | 1991-12-12 | 1993-12-07 | The Biomembrane Institute | Method for inhibiting selectin-dependent adhesion of leukocytes and platelets by O-glycosylation modification |
| US5605893A (en) * | 1994-03-15 | 1997-02-25 | Children's Hospital Of Los Angeles | Method of using a therapeutic food composition to diminish blood sugar fluctuations in diabetic patients |
| US5843921A (en) | 1994-03-15 | 1998-12-01 | Childrens Hospital Of Los Angeles | Therapeutic food composition and method to diminish blood sugar fluctuations |
| JP3580900B2 (ja) * | 1995-04-20 | 2004-10-27 | ホクレン農業協同組合連合会 | α−グルコシダーゼ阻害剤を含む糖を主体とする組成物を有効成分とする食品及び飼料 |
| US5929037A (en) * | 1995-06-07 | 1999-07-27 | Alberta Research Council | Modified α-D-Glcρ-(1-2)-α-D-Glcρ-(1-3)-α-D-Glcρ-analogues |
| EP0858335B1 (en) * | 1995-09-08 | 2003-03-12 | Novo Nordisk A/S | 2-alkylpyrrolidines |
| AU4335997A (en) * | 1996-09-09 | 1998-03-26 | Wisconsin Alumni Research Foundation | Human salivary proteins and fragments thereof having alpha-glucosidase inhibitory activity |
| US6534487B1 (en) | 1999-08-03 | 2003-03-18 | Childrens Hospital Los Angeles | Methods for suppressing appetite and enhancing exercise and recovery |
| CA2397578A1 (en) * | 1999-12-21 | 2001-06-28 | Ajinomoto Co., Inc. | A partial ester of a nitrogenous carboxylic acid with cellulose and a process for preparing the same |
| JP4486792B2 (ja) * | 2003-06-12 | 2010-06-23 | 学校法人近畿大学 | 環状オニウム化合物およびグルコシダーゼ阻害剤 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NO154918C (no) * | 1977-08-27 | 1987-01-14 | Bayer Ag | Analogifremgangsmaate til fremstilling av terapeutisk aktive derivater av 3,4,5-trihydroksypiperidin. |
-
1989
- 1989-10-10 EP EP89402794A patent/EP0422307A1/en not_active Withdrawn
-
1990
- 1990-09-17 US US07/583,545 patent/US5097023A/en not_active Expired - Fee Related
- 1990-09-21 EP EP90402613A patent/EP0422975B1/en not_active Expired - Lifetime
- 1990-09-21 DK DK90402613.5T patent/DK0422975T3/da active
- 1990-09-21 AT AT90402613T patent/ATE109153T1/de not_active IP Right Cessation
- 1990-09-21 DE DE69011033T patent/DE69011033T2/de not_active Expired - Fee Related
- 1990-09-21 ES ES90402613T patent/ES2060980T3/es not_active Expired - Lifetime
- 1990-10-04 AU AU63756/90A patent/AU632855B2/en not_active Ceased
- 1990-10-04 ZA ZA907936A patent/ZA907936B/xx unknown
- 1990-10-05 NZ NZ235578A patent/NZ235578A/en unknown
- 1990-10-05 TW TW079108368A patent/TW225539B/zh active
- 1990-10-09 IE IE361390A patent/IE64079B1/en not_active IP Right Cessation
- 1990-10-09 AR AR90318034A patent/AR246745A1/es active
- 1990-10-09 FI FI904965A patent/FI101796B/fi not_active IP Right Cessation
- 1990-10-09 IL IL9592890A patent/IL95928A/en not_active IP Right Cessation
- 1990-10-09 JP JP2269667A patent/JP3032266B2/ja not_active Expired - Fee Related
- 1990-10-09 PT PT95547A patent/PT95547B/pt not_active IP Right Cessation
- 1990-10-09 NO NO904372A patent/NO174203C/no not_active IP Right Cessation
- 1990-10-09 HU HU906389A patent/HU209724B/hu not_active IP Right Cessation
- 1990-10-10 KR KR1019900016003A patent/KR0183012B1/ko not_active IP Right Cessation
- 1990-10-10 CN CN90108284A patent/CN1029974C/zh not_active Expired - Fee Related
- 1990-10-10 CA CA002027276A patent/CA2027276C/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL90463A0 (en) | Novel alpha-glucosidase inhibitors | |
| ZA905737B (en) | Novel peptidase inhibitors | |
| IL85105A0 (en) | Novel peptidase inhibitors | |
| EP0457803A4 (en) | 4-hydroxythiazoles as 5-lipoxygenase inhibitors | |
| ZA904715B (en) | Novel acetylcholinesterase inhibitors | |
| EP0365863A3 (en) | Novel quinolyloxazole-2-ones useful as proteinkinase c inhibitors | |
| EP0405242A3 (en) | Vip-analogs ii | |
| ZA907936B (en) | Novel alpha-glucosidase inhibitors | |
| GR871770B (en) | Renin inhibitors | |
| EP0415634A3 (en) | Benzazabicyclic carbamates as cholinesterase inhibitors | |
| ZW9087A1 (en) | Dopamine-b-hydroxylase inhibitors | |
| ZA902279B (en) | Novel alpha-glucosidase inhibitors | |
| GB9003724D0 (en) | Toychest ii | |
| EP0427939A3 (en) | Renin inhibitors | |
| ZA908934B (en) | Novel pyridyloxazole-2-ones useful as proteinkinase c inhibitors | |
| IE893832L (en) | DOPAMINE-ß-HYDROXYLASE INHIBITORS | |
| ZA88285B (en) | Novel peptidase inhibitors | |
| IE872276L (en) | DOPAMINE-ß-HYDROXYLASE INHIBITORS | |
| GB8909878D0 (en) | Inhibitor | |
| CS862387A1 (en) | Smesny inhibitor koroze oceli | |
| CS25787A1 (en) | Inhibitor koroze | |
| IE890075L (en) | Renin inhibitors | |
| IE894102L (en) | Renin inhibitors | |
| IE891826L (en) | Renin inhibitors | |
| IE862056L (en) | DOPAMINE-ß-HYDROXYLASE INHIBITORS |